Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Asset Writedowns and Impairment (2024)

Bioadaptives' Asset Writedowns and Impairment history spans 1 years, with the latest figure at -$63350.0 for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$63350.0; the TTM value through Sep 2025 reached -$3350.0, changed N/A, while the annual FY2024 figure was $18000.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was -$63350.0 at Bioadaptives, down from $60000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $60000.0 in Q3 2024 and bottomed at -$63350.0 in Q4 2024.